Omada Health, Inc. (NASDAQ:OMDA) Given Average Recommendation of “Moderate Buy” by Analysts

Omada Health, Inc. (NASDAQ:OMDA) has earned an average recommendation of “Moderate Buy” from the eleven analysts that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and eight have assigned a buy rating to the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is $25.10.

A number of equities analysts have issued reports on the company. Barclays lowered their target price on Omada Health from $29.00 to $22.00 and set an “overweight” rating for the company in a report on Monday, January 5th. Weiss Ratings reiterated a “sell (d)” rating on shares of Omada Health in a report on Thursday, January 22nd. Wells Fargo & Company initiated coverage on shares of Omada Health in a research report on Thursday, January 8th. They issued an “equal weight” rating and a $17.00 price target for the company. BMO Capital Markets initiated coverage on shares of Omada Health in a research note on Thursday, November 13th. They set an “outperform” rating and a $27.00 price target for the company. Finally, The Goldman Sachs Group restated a “buy” rating and issued a $26.00 price objective on shares of Omada Health in a report on Friday, January 16th.

Omada Health Stock Performance

Shares of OMDA opened at $11.31 on Wednesday. Omada Health has a 52 week low of $10.28 and a 52 week high of $28.40. The stock has a market capitalization of $654.96 million and a price-to-earnings ratio of -45.24. The stock has a fifty day moving average of $14.89 and a 200-day moving average of $19.39.

Insider Activity

In related news, President Wei-Li Shao sold 5,618 shares of Omada Health stock in a transaction that occurred on Monday, December 29th. The stock was sold at an average price of $16.13, for a total value of $90,618.34. Following the transaction, the president directly owned 69,079 shares of the company’s stock, valued at $1,114,244.27. The trade was a 7.52% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Sean P. Duffy sold 40,796 shares of the business’s stock in a transaction that occurred on Tuesday, January 13th. The stock was sold at an average price of $15.95, for a total transaction of $650,696.20. Following the completion of the transaction, the chief executive officer owned 126,644 shares in the company, valued at $2,019,971.80. This trade represents a 24.36% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 276,893 shares of company stock valued at $4,336,787.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Marshall Wace LLP acquired a new stake in Omada Health in the fourth quarter worth $3,442,000. Archon Capital Management LLC boosted its position in shares of Omada Health by 125.1% during the 4th quarter. Archon Capital Management LLC now owns 678,120 shares of the company’s stock worth $10,701,000 after purchasing an additional 376,808 shares in the last quarter. AlpInvest Partners B.V. acquired a new stake in shares of Omada Health in the 4th quarter valued at about $850,000. Walleye Capital LLC increased its position in Omada Health by 59.1% in the 4th quarter. Walleye Capital LLC now owns 45,346 shares of the company’s stock valued at $716,000 after buying an additional 16,846 shares in the last quarter. Finally, Quarry LP acquired a new position in Omada Health during the 4th quarter worth approximately $29,000.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.